BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 27538463)

  • 1. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
    Unsinn C; Das A; Valayannopoulos V; Thimm E; Beblo S; Burlina A; Konstantopoulou V; Mayorandan S; de Lonlay P; Rennecke J; Derbinski J; Hoffmann GF; Häberle J
    Orphanet J Rare Dis; 2016 Aug; 11(1):116. PubMed ID: 27538463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants associated with urea cycle disorders in Japanese patients: Nationwide study and literature review.
    Kido J; Matsumoto S; Sugawara K; Sawada T; Nakamura K
    Am J Med Genet A; 2021 Jul; 185(7):2026-2036. PubMed ID: 33851512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urea cycle disorders in Argentine patients: clinical presentation, biochemical and genetic findings.
    Silvera-Ruiz SM; Arranz JA; Häberle J; Angaroni CJ; Bezard M; Guelbert N; Becerra A; Peralta F; de Kremer RD; Laróvere LE
    Orphanet J Rare Dis; 2019 Aug; 14(1):203. PubMed ID: 31426867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Application of Next-Generation Sequencing (NGS) in Neonatal-Onset Urea Cycle Disorders (UCDs): Clinical Course, Metabolomic Profiling, and Genetic Findings in Nine Chinese Hyperammonemia Patients.
    Zhou Q; Huang H; Ma L; Zhu T
    Biomed Res Int; 2020; 2020():5690915. PubMed ID: 32934962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological findings in livers of patients with urea cycle disorders.
    Yaplito-Lee J; Chow CW; Boneh A
    Mol Genet Metab; 2013 Mar; 108(3):161-5. PubMed ID: 23403242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urea cycle disorders in Thai infants: a report of 5 cases.
    Wasant P; Srisomsap C; Liammongkolkul S; Svasti J
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S720-31. PubMed ID: 12403252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of citrulline substitution on clinical outcome after liver transplantation in carbamoyl phosphate synthetase 1 and ornithine transcarbamylase deficiency.
    Aldrian D; Waldner B; Vogel GF; El-Gharbawy AH; McKiernan P; Vockley J; Landau YE; Al Mutairi F; Stepien KM; Kwok AM; Yıldız Y; Honzik T; Kelifova S; Ellaway C; Lund AM; Mori M; Grünert SC; Scholl-Bürgi S; Zöggeler T; Oberhuber R; Schneeberger S; Müller T; Karall D
    J Inherit Metab Dis; 2024 Mar; 47(2):220-229. PubMed ID: 38375550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
    Enns GM; Berry SA; Berry GT; Rhead WJ; Brusilow SW; Hamosh A
    N Engl J Med; 2007 May; 356(22):2282-92. PubMed ID: 17538087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Inomata Y; Kasahara M; Sakamoto S; Horikawa R; Tanemura A; Okajima H; Suzuki T; Nakamura K
    J Inherit Metab Dis; 2021 Nov; 44(6):1311-1322. PubMed ID: 34232532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disorders.
    Longo N; Diaz GA; Lichter-Konecki U; Schulze A; Inbar-Feigenberg M; Conway RL; Bannick AA; McCandless SE; Zori R; Hainline B; Ah Mew N; Canavan C; Vescio T; Kok T; Porter MH; Berry SA
    Mol Genet Metab; 2021 Jan; 132(1):19-26. PubMed ID: 33388234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency.
    Choi Y; Oh A; Lee Y; Kim GH; Choi JH; Yoo HW; Lee BH
    Clin Chim Acta; 2022 Feb; 526():55-61. PubMed ID: 34973183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment.
    Kido J; Matsumoto S; Mitsubuchi H; Endo F; Nakamura K
    Metab Brain Dis; 2018 Oct; 33(5):1517-1523. PubMed ID: 29948653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal factors related to survival and intellectual and developmental outcome of patients with early-onset urea cycle disorders.
    Pontoizeau C; Roda C; Arnoux JB; Vignolo-Diard P; Brassier A; Habarou F; Barbier V; Grisel C; Abi-Warde MT; Boddaert N; Kuster A; Servais A; Kaminska A; Hennequin C; Dupic L; Lesage F; Touati G; Valayannopoulos V; Chadefaux-Vekemans B; Oualha M; Eisermann M; Ottolenghi C; de Lonlay P
    Mol Genet Metab; 2020 Jun; 130(2):110-117. PubMed ID: 32273051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-onset diagnosis of urea cycle disorders: Results of a French cohort of 71 patients.
    Toquet S; Spodenkiewicz M; Douillard C; Maillot F; Arnoux JB; Damaj L; Odent S; Moreau C; Redonnet-Vernhet I; Mesli S; Servais A; Noel E; Charriere S; Rigalleau V; Lavigne C; Kaphan E; Roubertie A; Besson G; Bigot A; Servettaz A; Mochel F; Garnotel R
    J Inherit Metab Dis; 2021 Sep; 44(5):1199-1214. PubMed ID: 34014557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.
    Kölker S; Garcia-Cazorla A; Valayannopoulos V; Lund AM; Burlina AB; Sykut-Cegielska J; Wijburg FA; Teles EL; Zeman J; Dionisi-Vici C; Barić I; Karall D; Augoustides-Savvopoulou P; Aksglaede L; Arnoux JB; Avram P; Baumgartner MR; Blasco-Alonso J; Chabrol B; Chakrapani A; Chapman K; I Saladelafont EC; Couce ML; de Meirleir L; Dobbelaere D; Dvorakova V; Furlan F; Gleich F; Gradowska W; Grünewald S; Jalan A; Häberle J; Haege G; Lachmann R; Laemmle A; Langereis E; de Lonlay P; Martinelli D; Matsumoto S; Mühlhausen C; de Baulny HO; Ortez C; Peña-Quintana L; Ramadža DP; Rodrigues E; Scholl-Bürgi S; Sokal E; Staufner C; Summar ML; Thompson N; Vara R; Pinera IV; Walter JH; Williams M; Burgard P
    J Inherit Metab Dis; 2015 Nov; 38(6):1041-57. PubMed ID: 25875215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Nakajima Y; Wada Y; Mochizuki N; Murayama K; Lee T; Mochizuki H; Watanabe Y; Horikawa R; Kasahara M; Nakamura K
    J Inherit Metab Dis; 2021 Jul; 44(4):826-837. PubMed ID: 33840128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency.
    McBride KL; Miller G; Carter S; Karpen S; Goss J; Lee B
    Pediatrics; 2004 Oct; 114(4):e523-6. PubMed ID: 15466081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective treatment of urea cycle disorders.
    Maestri NE; Hauser ER; Bartholomew D; Brusilow SW
    J Pediatr; 1991 Dec; 119(6):923-8. PubMed ID: 1720458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonemia in a patient with late-onset ornithine carbamoyltransferase deficiency.
    Choi DE; Lee KW; Shin YT; Na KR
    J Korean Med Sci; 2012 May; 27(5):556-9. PubMed ID: 22563224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.